Meridian Medical Technologies, Inc.

Website Links

Description

Since the 1960s, the company has partnered with and served as a critical supplier for the U.S. Department of Defense (DOD). Today, Meridian is the only supplier of FDA-approved auto-injectors containing nerve agent antidotes, and has produced in excess of 185 million auto-injectors for the world market. As Meridian continues to excel on decades of development and manufacturing experience, the company maintains its focus on producing high-quality prescription auto-injectors that meet the demanding operational needs of emergency responders, the U.S. armed forces, and allied military personnel around the world.Each auto-injector is a pre-filled, ready to use, pressure-activated device designed for the quick administration of a precise dose of medication. Unlike a syringe, which can be cumbersome and time-consuming, Meridian’s auto-injectors provide a compact, quick and portable delivery system. The design’s simplicity, concealed needle, and speed of injection render these auto-injectors well suited for self administration or by a caregiver.On November 29, 2004, Meridian Medical Technologies, Inc. announced that the U.S. Food and Drug Administration (FDA) approved AtroPen® 0.25 mg (atropine injection) for infants weighing less than 15 pounds, generally less than 6 months of age. AtroPen® is an antidote for chemical nerve agent poisoning. With this most recent approval, AtroPen® is now available in dosages for patients of all ages. For more information see Media Release: Chemical Nerve Agent Antidote Now Approved By FDA for Patients of All Ages, Including Infants.

Fact sheet

Company contacts

Products & services

Similar companies nearby